EXCLUSIVE: Major Novartis shareholder calls for board shake-up after drug trial setbacks - Reuters
EXCLUSIVE: Major Novartis shareholder calls for board shake-up after drug trial setbacks Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNRXkycUxwWU1iSXF2SUJuVWxOTHZ6ZDVlYW5aZS1wdlhDUzBlSHNqZkQtbFlvZ1dhYkRkNmpobW9pT0NPeE82MmJfdVFnaUlNZ1J3emlGc3dDdHhpUTBGTFhTdFg1R0hnRTR5a3FnUjI5Wnh5d2d0R0llaUNoNHJfMXpUSmVsc2VlM0swd1lpQU91T0pGanZGZ1gxSTBpY3B3NVpoSlppVk1Ob1ZqODRXNExtT01RQQ?oc=5" target="_blank">EXCLUSIVE: Major Novartis shareholder calls for board shake-up after drug trial setbacks</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Wegovy maker Novo shares slump as management grilled on pricing, M&A - Reuters
Wegovy maker Novo shares slump as management grilled on pricing, M&A Reuters
September 21, 2026 at 01:21 PMWegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs - reuters.com
Wegovy-maker Novo faces calls to map out strategy beyond weight-loss drugs reuters.com
September 21, 2026 at 05:02 AMNanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology - Reuters
Nanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology Reuters
September 25, 2026 at 02:14 PMUBS dealt blow as Swiss upper house backs tougher 90% capital plan - Reuters
UBS dealt blow as Swiss upper house backs tougher 90% capital plan Reuters
September 23, 2026 at 11:58 AMADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO - Reuters
ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO Reuters
September 25, 2026 at 05:27 PMNovo Nordisk open to direct New York listing, CEO Doustdar tells FT - Reuters
Novo Nordisk open to direct New York listing, CEO Doustdar tells FT Reuters
September 23, 2026 at 04:13 AM